Silverarc Capital Management »

Caribou Biosciences shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.3M 893k 4.78

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Caribou Biosciences

Partner Fund Management
Avidity Partners Management
Vanguard Group
Point72 Asset Management
Paradigm Biocapital Advisors
Elmwood Wealth Management
Bank of America Corporation
Dimensional Fund Advisors
Kynam Capital Management
Candriam Luxembourg S.C.A.
Rokos Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Maverick Capital
Jpmorgan Chase & Co

View all funds holding Caribou Biosciences